drugset / Trial / NCT02806908

Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy

NCT02806908

Phase 2 Completed 24 enrolled Jazz Pharmaceuticals
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is a randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of JZP-110 on driving performance in subjects with excessive sleepiness due to narcolepsy.

Timeline

Start
2016-06
Primary completion
2019-05-19
Completion
2019-05-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator Solriamfetol Small molecule 300 mg

Indications